Zhehan Bao

发表

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer

Yi Wang, Pengcheng Yu, Yunfu Shi, 2022, Frontiers in Oncology.

Preoperative chemotherapy combined with para-aortic lymph node dissection has clinical value in the treatment of gastric cancer with para-aortic lymph node metastases

Pengcheng Yu, Ruolan Zhang, Zhehan Bao, 2022, BMC Surgery.

Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer

Pengcheng Yu, Ruolan Zhang, Xiang-dong Cheng, 2022, Annals of translational medicine.

High CHAF1A Expression Levels Are Positively-Correlated with PD-L1 Expression and Indicate Poor Prognosis in Gastric Cancer

Pengcheng Yu, Y. Xia, Yi Wang, 2022, Evidence-based complementary and alternative medicine : eCAM.

Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer

Pengcheng Yu, Ruolan Zhang, Jiaqing Zhang, 2023, BMC Cancer.

Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study

X. Liu, Yanan Wang, Yingwei Xue, 2023, EClinicalMedicine.

SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer

Pengcheng Yu, Y. Xia, Ruolan Zhang, 2022, Journal of oncology.

Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients

Chencui Huang, Li-tao Yang, Z. Ye, 2023, International journal of surgery.

Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers

Zhehan Bao, Yi Wang, Xiang-Dong Cheng, 2024, World Journal of Gastrointestinal Oncology.

World Journal of Gastrointestinal Oncology

Zhehan Bao, Xiang-Dong Cheng, Can Hu, 2022 .